期刊文献+

药物洗脱支架与裸支架介入治疗冠心病的对比研究 被引量:7

The clinical research of drug-eluting stent used in the treatment of coronary heart disease
下载PDF
导出
摘要 目的比较冠心病患者应用药物洗脱支架与应用裸支架的安全性和有效性。方法回顾我院2006—2011年行冠脉支架置入术患者的随访结果,比较应用药物洗脱支架与裸支架的再狭窄率。结果应用药物洗脱支架患者的再狭窄率为8%,应用裸支架患者的再狭窄率为25%,两者相比差异有统计学意义。结论药物洗脱支架较裸支架具有更低的支架内再狭窄发生率。 Objective To study the safety and efficacy of application of drug-eluting stents and bare metal stent in patients with coronary heart disease. Methods The patients underwent coronary stent implantation in our hospital (2006-2011) were retrospective analyzed. The restenosis rate was compared between the two kinds of stents. Results The restenosis rate in drug-eluting stents group was of 1.7%, and in bare metal stents group was 8.8%, there was a significant difference between two groups. Conclusion Compared with bare metal stent, drug-eluting stents has a lower in-stent restenosis.
作者 于维雅
出处 《中国心血管病研究》 CAS 2012年第12期911-912,共2页 Chinese Journal of Cardiovascular Research
关键词 冠状动脉疾病 药物洗脱支架 裸支架 支架内再狭窄 Coronary heart disease Drug-eluting stents Bare stent Restenosis
  • 相关文献

参考文献4

  • 1张正海,张学坤,郭金城,甘舜进,张立宾.国产药物洗脱支架早期介入治疗急性心肌梗死疗效观察[J].中国心血管病研究,2009,7(1):26-27. 被引量:2
  • 2Kobayashi Y, Degregorio J, Kobayashi N, et al. Stented segment length as an independent predictor for restenosis. J Am Coil Caradiol, 1999,34 : 651-659.
  • 3Regar E, Serruys PW, Bode C, et al. Angiographie findings of the multicenter randomized study with the sirolomus-eluting Bx veioeity balloon-expandable stent (RAVEL). Circulation,2002, 106 : 1949-1964.
  • 4Grube E, Silber SM, Hauptmann KE, et al. TAXUSI:six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation, 2003,107 : 517-520.

共引文献1

同被引文献49

  • 1谢阳,吴强,邝鸿生,许百洁,林宇鹏,吴敏.药物洗脱支架与金属裸支架联合氯吡格雷治疗冠心病远期疗效对比[J].中国老年学杂志,2014,34(1):60-62. 被引量:10
  • 2刘灵芝,侯翠红,刘恒亮.冠脉内支架植入术后再狭窄的影响因素分析[J].郑州大学学报(医学版),2005,40(3):533-535. 被引量:8
  • 3苏林,刘学波,葛均波.糖尿病与冠脉支架再狭窄的关系分析[J].中国临床医学,2005,12(4):578-580. 被引量:19
  • 4Briguori C, Sarais C, Pagnotta P, et al. In stent restenosis in small coronsry arteries., impact of strut thickness [J]. Jamer Coll of Cardiology, 2002,40(3) :403 - 409.
  • 5Targher G, Bertolini L, Zenari L, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients[J]. Diabet Med, 2008,25(1):45-50. DOI: 10.1111/j.1464-5491.2007.02327.x.
  • 6Boyden TF, Nallamothu BK, Moscucci M, et al. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus[J]. Am J Cardiol, 2007,99(10):1399-1402.
  • 7Targher G, Bertolini L, Zoppini G, et al. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen[J]. Diabetes Care, 2007,30(6):e51; author reply e52.
  • 8Patti G, Nusca A, Di Sciascio G. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus[J]. Am J Cardiol, 2008,102(10):1328-1334. DOI: 10.1016/j.amjcard.2008.07.012.
  • 9Almalla M, Schrder JW, Pross V, et al. Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents[J]. Coron Artery Dis, 2013,24(2):165-170. DOI: 10.1097/MCA.0b013e32835c8fb2.
  • 10Kawasaki S, Misawa H, Tamura Y, et al. Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus[J]. Intern Med, 2013,52(22):2483-2487.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部